Lightnews — Scholar-powered news

Navigating Clarity in a Cloudy Vaccine Landscape: ACIP’s September 2025 Decisions and What They Mean for Clinical Practice

Matt Hoffman @bymatthoffman.bsky.social · 7d

A lot happened last month in the @cdcgov.govmirrors.com's latest ACIP vaccines meeting. Amid the debate, though, there was clinically relevant conversation. @contagionlive.bsky.social was on the case with coverage, and I did my best to summarize some of that here:
www.linkedin.com/pulse/naviga...

In what perhaps came as no surprise, this month’s Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) meeting—taking place over the 2-day span of September 1...

www.linkedin.com

FDA CBER Director Resigns Amid Gene Therapy Controversy and COVID-19 Vaccine Policy Changes

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Jul 30

🚨 Dr. Vinay Prasad resigns as the FDA’s CBER Director after months marked by tough gene therapy disputes & changes to #COVID19 vaccine policies. His cautious, evidence-based leadership sparked debate amid safety & political concern #IDsky #MEDsky

More details: www.contagionlive.com/view/fda-cbe...

Vinay Prasad’s, MD, MPH, short tenure marked by tough regulatory decisions and political pushback; the Trump administration has not yet named a successor for the CBER director role.

Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients

1 2

Reposted by Matt Hoffman

NeurologyLive® @neurologylive.bsky.social · May 30

Multiple sclerosis isn’t just relapses and mobility issues. Fatigue, cognitive dysfunction, and emotional well-being matter too.

Dr. Taylor Hess breaks it all down in our latest episode for #WorldMSDay 🎙️
➡️ www.neurologylive.com/view/episode...

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Taylor Hess, MD. [LISTEN TIME: 10 minutes]

FDA Grants Fast Track Status to ARCT-2304 for H5N1 Influenza Protection

Reposted by Matt Hoffman

International Journal of MS Care @ijmsc.bsky.social · May 28

So many opportunities to learn and network at #CMSC2025. Where will we see you? And this year is especially poignant as we remember June Halper, a Giant of #MS, and a woman who devoted herself to the #CMSC community.

1 1 2

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Apr 10

The FDA has granted Fast Track Designation to ARCT-2304, an investigational sa-mRNA vaccine from Arcturus Therapeutics aimed at protecting against #H5N1 influenza, accelerating its development. #birdflu #avianinfluenza #IDsky #MEDsky

Read here: www.contagionlive.com/view/fda-gra...

Investigational sa-mRNA vaccine advances to phase 1 trials for pandemic preparedness

ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD

Matt Hoffman @bymatthoffman.bsky.social · Apr 8

Ep 3 of @cgtlive.bsky.social's #ImmunoLogic podcast with Joseph Fraietta, PhD, and Janna Minehart, MD, is now live! Our guest is Marcela Maus, MD, PhD, of @massgeneralbrigham.bsky.social to talk about her research into the use of #CART therapy to treat #glioblastoma.
www.cgtlive.com/view/immunol...

In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.

www.cgtlive.com

Reposted by Matt Hoffman

International Journal of MS Care @ijmsc.bsky.social · Apr 7

"Exposure to a dedicated young-adult #virtual support group may provide a sense of normalcy, belonging, and validation and may give #YoungAdults the opportunity to interact and communicate with #peers living with" #MultipleSclerosis.
doi.org/10.7224/1537...

Reposted by Matt Hoffman

NeurologyLive® @neurologylive.bsky.social · Apr 7

Last Friday, we launched the latest episode of our Mind Moments podcast, featuring expert insight from special guest @danharrisonmd.bsky.social! In this 20-min convo, we discuss everything regarding NP education, including the changing roles of NPs:

Listen in 🎙️ www.neurologylive.com/view/episode...

Second Measles Death In Texas

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Apr 7

A child who was not vaccinated succumbed to #measles pulmonary failure. Additionally, increased cases and hospitalizations continue to grow greatly in the state. #IDsky #medsky

A child who was not vaccinated succumbed to measles pulmonary failure. Additionally, increased cases and hospitalizations continue to grow greatly in the state.

1 4

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Apr 4

We launched our interactive Spring 2025 Issue. Come check it out! #IDsky #Medsky

Read the issue here: www.contagionlive.com/publications...

3 6

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Mar 19

ICYMI: Dr. Moupali Das presented data at #CROI2025 showing Gilead's once-yearly Lenacapavir formulations for HIV PrEP sustain efficacy for 56 weeks. This phase 1 study paves the way for improved adherence & HIV prevention. #IDsky #HIVsky #MEDsky

Learn more: www.contagionlive.com/view/gilead-...

Blueprints for Better Care: 2024 Neurology Guideline Highlights

Matt Hoffman @bymatthoffman.bsky.social · Mar 12

There were ~several~ clinical care guidelines that were updated in 2024, shaping the way physicians diagnose and treat. The @neurologylive.bsky.social team put together a wonderful overview of all of those changes, in a single resource:
www.neurologylive.com/view/bluepri...

Explore the key 2024 neurology guideline updates shaping clinical care across stroke, epilepsy, movement disorders, and more in this essential feature.

ImmunoLogic, Episode 2: "Charting New Frontiers in CAR T-Cell Safety" With Bruce Levine, PhD

Matt Hoffman @bymatthoffman.bsky.social · Mar 11

Episode 2 of @cgtlive.bsky.social's podcast, #ImmunoLogic, is here!! 🎙️ Joseph Fraietta, PhD, and Janna Minehart, MD, spoke with Bruce Levine, PhD, to explore the @fda.gov’s black box warnings in CAR-T therapy and the NIH's role in advancing #CART research, among other topics.

Check it out here:

In Episode 2 of ImmunoLogic, Bruce Levine, PhD, discussed the current the risk-benefit-ratio for CAR-T therapy.

www.cgtlive.com

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Mar 7

New Mexico resident has died after testing positive for #Measles, though the official cause of death is still under investigation. They were unvaccinated & did not seek medical care prior to passing. The NMDOH urges residents to get vaccinated. #IDsky #MEDsky

www.contagionlive.com/view/measles...

Measles-Positive New Mexico Resident Dies, Cause of Death Still Unconfirmed

The official cause of death is still under investigation by the New Mexico Office of the Medical Investigator, though the individual tested positive for the measles virus.

2 1

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Mar 6

ICYMI: Dr. Manjot Gill from @NorthwesternMed Medicine discusses how a study on retinal capillary perfusion in #LongCOVID patients may provide valuable insights into the neuro effects of the condition & offer markers for diagnosis & treatment. #IDsky #MEDsky

www.contagionlive.com/view/retinal...

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Feb 28

See you in San Francisco at #CROI2025 🌉🏙️

Contagion will be at CROI March 9-12— we are excited to connect with you and share your research! #IDsky #MEDsky

50 Years in Ophthalmology: A look at glaucoma treatments

Matt Hoffman @bymatthoffman.bsky.social · Feb 28

Did you know: 2025 marks the 50th(!!!) year of Ophthalmology Times?

At the American Glaucoma Society meeting, we heard from John Berdahl, MD; Inder Paul Singh, MD; and Shan Lin, MD on just how much has changed in those 5 decades. #AGS2025
www.ophthalmologytimes.com/view/50-year...

We asked ophthalmologists what stands out to them in the history of treating glaucoma and where future treatments might be heading.

www.ophthalmologytimes.com

Matt Hoffman @bymatthoffman.bsky.social · Feb 28

For #RareDiseaseDay, @neurologylive.bsky.social had a few recent conversations worth reading:

Amber Freed, on her journey and advocacy efforts: www.neurologylive.com/view/rare-di...

Mary Schroth, MD, on the efforts in SMA:
www.neurologylive.com/view/rare-di...

Rare Disease Day 2025: Transforming Challenges Into Action for SLC6A1

Amber Freed, founder of SLC6A1 Connect, shared her personal journey and advocacy efforts to raise awareness for SLC6A1, a rare genetic epilepsy, in honor of Rare Disease Day.

3 Case of Measles Reported in New Jersey

Matt Hoffman @bymatthoffman.bsky.social · Feb 27

The @neurologylive.bsky.social team is on site at the #actrims2025 forum in West Palm Beach!

Follow along here for all of the coverage, interviews, and updates:
www.neurologylive.com/conferences/...

Reposted by Matt Hoffman

Contagion® @contagionlive.bsky.social · Feb 27

The state’s health department has confirmed all 3 cases are in people who are unvaccinated. #measles #IDsky #Medsky

The state’s health department has confirmed all 3 cases are in people who are unvaccinated.

Measles: The Canary in the Coal Mine for Childhood Vaccine Decline

2 6 8

Matt Hoffman @bymatthoffman.bsky.social · Feb 27

From @contagionlive.bsky.social: A school-aged child has died from #measles in Texas—the first death in the ongoing outbreak, which now has 124 cases. CHOP's Paul Offit, MD, warns that such outbreaks signal declining childhood vaccination rates.

Learn more:
www.contagionlive.com/view/measles...

On the heels of the first death in an ongoing US-based measles outbreak, Paul Offit, MD, discusses how outbreaks are the first sign that childhood vaccination rates are starting to decline.

Envision Summit 2025: Insights and Takeaways

Matt Hoffman @bymatthoffman.bsky.social · Feb 19

The #Ophthalmology Times team is still cranking out interview content from last weekend's #EnVisionSummit (which you can find on our website).

If you're looking for some immediate takeaways from the interviews we've already posted, I've got you covered here:
www.linkedin.com/pulse/envisi...

Last weekend, Envision Summit 2025 brought together ophthalmologists, optometrists, and eye care specialists in San Juan, Puerto Rico, to participate in discussions on the recent advancements in clini...

www.linkedin.com

Matt Hoffman @bymatthoffman.bsky.social · Feb 14

AI can reshape scientific publishing, from manuscripts to peer review—but challenges around authorship, transparency, and integrity remain. How do we navigate its role while maintaining ethical standards?

#ArtificialIntelligence #ScientificPublishing
www.linkedin.com/pulse/balanc...

A Balancing Act: AI and Scientific Publishing

Over the past 18 months, we've all had at least one conversation with a colleague or a peer about artificial intelligence (AI). Whether about OpenAI's ChatGPT or Micosoft's Copilot—or one of the hundr...

www.linkedin.com

Matt Hoffman @bymatthoffman.bsky.social · Feb 3

For #NationalWomenPhysiciansDay, @neurologylive.bsky.social partnered with Carlayne Jackson, MD, FAAN, of @aanmember.bsky.social; Vanessa Hinson, MD, PhD, of @medunivsc.bsky.social; and Marie Eugene, DO, of @uconn.bsky.social for a topical discussion.

WATCH: www.neurologylive.com/view/episode...

Episode 1: Leadership and Legacy of Women Transforming Neurology

A group of empowering women leaders in neurology explore the transformative impact of women neurologists on the medical workforce and the strides toward a more inclusive neurology field.